Latest news

AstraZeneca’s Obesity Pill Shows Positive Results in Early Trial

AstraZeneca announced that its new weight-loss medication, which was licensed from Eccogene of China, underwent early-stage testing and was...

Novo scores license to use Ascendis’ TransCon platform for $285 million

In exchange for $285 million, Copenhagen-based Ascendis has agreed to help Novo Nordisk develop a once-a-month GLP-1 receptor antagonist...

Apellis and Novartis both target rare kidney diseases with new drugs

Apellis Pharmaceuticals and Novartis recently shared data for their rare kidney disease drugs, pegcetacoplan and iptacopan. Both have performed...

Astellas and Europe Clash Over Approval of Geographic Atrophy Drug Izervay

Izervay by Astellas and Syfovre by Apellis are the major rivals in the United States Geographic Atrophy (GA) market,...

After Roche and Takeda, Novartis steps into the molecular glue space

Roche first entered into an agreement with Orionis Biosciences...

Marinus to cut workforce and explore options after Ztalmy trial setback

Marinus Pharmaceuticals, a pharmaceutical company, has been dealt a blow after its Seizure drug, Ztalmy, did not reach the...

Arcus’ HIF-2a Inhibitor Shows Positive Response Rate in Study

The latest research on Arcus Biosciences' experimental HIF-2a inhibitor suggests that the firm may provide significant competition to Merck's...

Merck-Gilead’s Combined HIV Treatment Sunlenca Shows Positive Results in Mid-Phase Clinical Trial

A mid-phase trial featuring Gilead Sciences and Merck & Co.'s once-weekly HIV combination therapy has successfully met its primary...

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

Common conditions in women such as PCOS, menopause, and...

New drug Roche to enter breast cancer therapy field

The Food and Drug Administration (FDA) has recently granted approval to Swiss company Roche’s inavolisib for treating HR-positive, HER2-negative...

Life Sciences Voice Top Five Newsletter

Welcome to the latest edition of the Life Sciences Voice Top Five Newsletter, your source for the latest news...

The medical device sector’s surging regulatory burden: how are suppliers coping?

Regulators around the world are increasing their scrutiny of medical devices as these become more critical to patient outcomes....

Novo scores license to use Ascendis’ TransCon platform for $285 million

In exchange for $285 million, Copenhagen-based Ascendis has agreed...

In an attempt to treat liver illness, Gilead buys CymaBay for $4.3 billion

Gilead Sciences has agreed to purchase CymaBay...

After opioid-meltdown, Mallinckrodt gets ready for company restructuring

Mallinckrodt has closed in on the reorganization...

Popular

Most popular life news you must read today

NRx Pharma’s ZYESAMI™ approved for emergency use Covid critical care in Georgia

As of July 27, a global biopharmaceutical company, NRx Pharmaceuticals, has announced that the Prime Minister of the Nation of Georgia

A Patient Centric Approach to Clinical Research is Key for Product Development

Ensuring a patient centric approach during clinical...

Commercial

Novo scores license to use Ascendis’ TransCon platform for $285 million

In exchange for $285 million, Copenhagen-based Ascendis has agreed to help Novo Nordisk develop a once-a-month GLP-1 receptor antagonist...

AbbVie Completes $1.4B Purchase of Aliada

AbbVie has agreed to spend $1.4 billion to purchase Aliada Therapeutics. Through this acquisition, AbbVie will be able to...

After Roche and Takeda, Novartis steps into the molecular glue space

Roche first entered into an agreement with Orionis Biosciences in 2023 and paid the company up to $2 billion...

Novartis strikes $1.1B deal with China’s Baiyu for a small molecule cancer contender

Novartis is investing over $70 million in Chengdu Baiyu Pharmaceutical to bolster its roster of cancer therapy prospects. It...

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

Common conditions in women such as PCOS, menopause, and endometriosis often lead to hormonal imbalances, resulting in irregular weight...

Maven Clinic receives $125 million to fund technology and value-based treatment

Maven Clinic, an online clinic for women and family health, has closed its series F funding round at $125...

Information Technology

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

Common conditions in women such as PCOS, menopause, and endometriosis often lead to hormonal...

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Health technology company PicnicHealth has launched a new product, Virtual Site, which allows researchers...

Elon Musk Announces Neuralink’s Second Brain-Computer Chip Implantation in a Patient

Neuralink, founded by Elon Musk, revealed that it has placed its device in the...

AI Firm Formation Bags $372 Series D Funding

In 2024, megarounds have been extremely uncommon. Nonetheless, Formation Bio was able to secure...

Regulatory

Astellas and Europe Clash Over Approval of Geographic Atrophy Drug Izervay

Izervay by Astellas and Syfovre by Apellis are the...

Novo scores license to use Ascendis’ TransCon platform for $285 million

In exchange for $285 million, Copenhagen-based Ascendis has agreed...

Apellis and Novartis both target rare kidney diseases with new drugs

Apellis Pharmaceuticals and Novartis recently shared data for their...

Astellas and Europe Clash Over Approval of Geographic Atrophy Drug Izervay

Izervay by Astellas and Syfovre by Apellis are the...

AbbVie Completes $1.4B Purchase of Aliada

AbbVie has agreed to spend $1.4 billion to purchase...

Research & Development

GSK Responds to Pfizer’s RSV Approval with Data Aiming for Similar Approval in Younger Adults

Two early-phase study trials suggest that GSK’s RSV vaccine, Arexvy, may benefit certain high-risk...

Developments in RNA Research Win Nobel Prizes for the Second Consecutive Year

After last year’s Nobel Prize in Physiology or Medicine was awarded to Drew Weissman...

Long-Term Immunotherapy Benefits For Melanoma Shown in Ten-Year Survival Data

Two medications have been shown to drastically alter the prognosis for the fatal skin...

Onward awarded $1.1M grant from the Christopher & Dana Reeve Foundation to advance BCI research

Onward Medical revealed that it has received a major grant from the Christopher &...

Market Access

Novo Nordisk Planning Huge $4.1B Plant in NC For Ozempic Production

It seems like GLP-1 giants Novo Nordisk and Eli Lilly are locked in a...

French Company Orano Med Opens New Radiation Production Facility Near Indianapolis

In a nuclear medicine surge, industry leader Orano Med has selected the U.S. as...

Gerresheimer Increases the Capabilities of Medical Systems in the USA

Gerresheimer, the maker of innovative systems and solutions and a partner to the pharma,...

Novo Nordisk invests $560 million to increase Chinese medicine production

Novo Nordisk, a prominent player in the pharmaceutical industry, is commemorating three decades of...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

AstraZeneca’s Obesity Pill Shows Positive Results in Early Trial

AstraZeneca announced that its new weight-loss medication, which was...